NXS 6.00% 26.5¢ next science limited

Q4 Revenue was US$7.1m with GP% back up to 78%.To achieve the...

  1. 219 Posts.
    lightbulb Created with Sketch. 119
    Q4 Revenue was US$7.1m with GP% back up to 78%.

    To achieve the bottom of the guidance range for 2024, Q on Q growth rate of 10% is required. For the last 2 years, NXS have averaged 24% Q on Q growth in revenue. This to me is the only small but real risk to achieving cashflow positive status. I think it will be achieved. Remember, guidance for 2024 is between $36 and $40m. 10% is all we are looking for!

    The rest of the variables in terms of EBITDA and cashflow are very much controllable.

    Admin & Mgmt Expenses are well in hand and registered only a 4% increase in 2023.
    R & D Expenses are again totally controllable and registered only a 7% increase in 2023.
    Selling & Distribution is where the cashflow has predominantly gone, but this expense is also very controllable.

    So by my reasoning, cashflow breakeven is very much on the cards for 2024. And if this is achieved, then I think we will be off to the races as far as the share price is concerned. There will be some resistance around 42c, then no real resistance until we reach 90c, $1.00 and $1.20

    I am a big fan of this stock and agree with your friend EDDYDudes. I expect we will see all time highs in this stock within the next 2 to 3 years.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
26.5¢
Change
0.015(6.00%)
Mkt cap ! $77.29M
Open High Low Value Volume
24.5¢ 26.5¢ 23.0¢ $49.73K 202.7K

Buyers (Bids)

No. Vol. Price($)
1 12845 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 3703 1
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
26.5¢
  Change
0.015 ( 6.00 %)
Open High Low Volume
25.5¢ 26.5¢ 23.0¢ 62089
Last updated 15.55pm 24/05/2024 ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.